Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	65.91B +10.2%
Revenue (ttm)	18.38B -8.0%
Net Income	1.57B -37.0%
EPS	0.99 -36.9%
Shares Out	1.59B
PE Ratio	41.85
Forward PE	28.96
Dividend	0.59 (1.28%)
Ex-Dividend Date	May 11, 2026

Volume	41,106,702
Open	44.87
Previous Close	44.87
Day's Range	41.24 - 44.88
52-Week Range	28.14 - 52.78
Beta	-0.17
Analysts	Buy
Price Target	46.54 (+12.31%)
Earnings Date	Aug 27, 2026

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 20,127
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2025, SHE:002422's revenue was 18.51 billion, a decrease of -15.13% compared to the previous year's 21.81 billion. Earnings were 1.70 billion, a decrease of -42.03%.

Analyst Summary

According to 7 analysts, the average rating for 002422 stock is "Buy." The 12-month stock price target is ¥46.54, which is an increase of 12.31% from the latest price.

Price Target

¥46.54

(12.31% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 24, 2026

Data Sources Report a data error